
Last update at 2026-06-03T18:18:00Z
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
Asahi Kasei Microdevices Launches New Series of Power Management ICs for Energy Harvesting
Tue 06 May 25, 12:30 PMAsahi Kasei Bioprocess America Wins Best Technologies Innovation Award at INTERPHEX 2025
Mon 28 Apr 25, 12:30 PMKen Shinomiya Becomes Leader of Asahi Kasei’s Healthcare Sector
Thu 24 Apr 25, 12:53 PMAsahi Kasei Establishes Asahi Kasei Life Science to Drive its Bioprocess Businesses Forward
Tue 08 Apr 25, 12:30 PM| Breakdown | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
| Income before tax | 194602.00M | 28843.00M | -61906.00000M | 215121.00M | 150906.00M |
| Minority interest | -5408.00000M | -2522.00000M | -1942.00000M | -1954.00000M | 27058.00M |
| Net income | 134997.00M | 43806.00M | -91312.00000M | 161880.00M | 79768.00M |
| Selling general administrative | - | - | - | - | - |
| Selling and marketing expenses | - | - | - | - | - |
| Gross profit | 958260.00M | 815969.00M | 773776.00M | 769768.00M | 680709.00M |
| Reconciled depreciation | 186106.00M | 182196.00M | 176651.00M | 148129.00M | 133272.00M |
| Ebit | 203698.00M | 36291.00M | 127443.00M | 215695.00M | 178627.00M |
| Ebitda | 389804.00M | 218487.00M | 304094.00M | 363824.00M | 311899.00M |
| Depreciation and amortization | 186106.00M | 182196.00M | 176651.00M | 148129.00M | 133272.00M |
| Non operating income net other | - | - | - | - | - |
| Operating income | 211921.00M | 140746.00M | 128352.00M | 202647.00M | 171808.00M |
| Other operating expenses | 2825391.00M | 2644132.00M | 2598133.00M | 2258671.00M | 1934243.00M |
| Interest expense | 9096.00M | 7448.00M | 5907.00M | 3643.00M | 3209.00M |
| Tax provision | 54197.00M | -17485.00000M | 27464.00M | 51287.00M | 68808.00M |
| Interest income | 9982.00M | 7684.00M | 3896.00M | 1364.00M | 1895.00M |
| Net interest income | 886.00M | 236.00M | -2011.00000M | -2279.00000M | -1314.00000M |
| Extraordinary items | - | - | - | - | - |
| Non recurring | - | - | - | - | - |
| Other items | - | - | - | - | - |
| Income tax expense | 54197.00M | -17485.00000M | 27464.00M | 51287.00M | 68808.00M |
| Total revenue | 3037312.00M | 2784878.00M | 2726485.00M | 2461317.00M | 2106051.00M |
| Total operating expenses | 746340.00M | 675223.00M | 645424.00M | 567122.00M | 508901.00M |
| Cost of revenue | 2079051.00M | 1968909.00M | 1952709.00M | 1691549.00M | 1425342.00M |
| Total other income expense net | -17319.00000M | -111903.00000M | -190258.00000M | 12475.00M | -20902.00000M |
| Discontinued operations | - | - | - | - | - |
| Net income from continuing ops | 140405.00M | 46328.00M | -89370.00000M | 163834.00M | 82098.00M |
| Net income applicable to common shares | - | - | - | 161880.00M | 79768.00M |
| Preferred stock and other adjustments | - | - | - | - | - |
| Breakdown | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
| Total assets | 4015214.00M | 3662730.00M | 3454526.00M | 3349075.00M | 2918941.00M |
| Intangible assets | 540913.00M | 394052.00M | 368695.00M | 405508.00M | 342453.00M |
| Earning assets | - | - | - | - | - |
| Other current assets | 165237.00M | 150029.00M | 151769.00M | 114724.00M | 94906.00M |
| Total liab | 2101270.00M | 1814105.00M | 1758517.00M | 1630259.00M | 1424407.00M |
| Total stockholder equity | 1859421.00M | 1813391.00M | 1660922.00M | 1687411.00M | 1467476.00M |
| Deferred long term liab | - | - | - | - | - |
| Other current liab | 434061.00M | 384587.00M | 110685.00M | 110779.00M | 88532.00M |
| Common stock | 103389.00M | 103389.00M | 103389.00M | 103389.00M | 103389.00M |
| Capital stock | 103389.00M | 103389.00M | 103389.00M | 103389.00M | 103389.00M |
| Retained earnings | 1191076.00M | 1135533.00M | 1142325.00M | 1282325.00M | 1158792.00M |
| Other liab | - | - | - | 283910.00M | 286919.00M |
| Good will | 389640.00M | 360676.00M | 368089.00M | 431335.00M | 351921.00M |
| Other assets | - | - | - | 1.00M | 1.00M |
| Cash | 393467.00M | 338108.00M | 251181.00M | 244641.00M | 221779.00M |
| Cash and equivalents | - | - | - | - | - |
| Total current liabilities | 964608.00M | 914572.00M | 912163.00M | 923850.00M | 703163.00M |
| Current deferred revenue | - | 83034.00M | 254120.00M | 280264.00M | 243093.00M |
| Net debt | 801578.00M | 617453.00M | 723567.00M | 532574.00M | 441997.00M |
| Short term debt | 318298.00M | 298906.00M | 366798.00M | 354715.00M | 229451.00M |
| Short long term debt | 310249.00M | 291091.00M | 360032.00M | 352491.00M | 228571.00M |
| Short long term debt total | 1195045.00M | 955561.00M | 974748.00M | 777215.00M | 663776.00M |
| Other stockholder equity | 564956.00M | 574469.00M | -1245714.00000M | -1385714.00000M | -1262181.00000M |
| Property plant equipment | - | - | - | 805215.00M | 717262.00M |
| Total current assets | 1769448.00M | 1650037.00M | 1488195.00M | 1334209.00M | 1136776.00M |
| Long term investments | - | - | - | - | - |
| Net tangible assets | - | - | - | 850567.00M | 773101.00M |
| Short term investments | - | -93399.00000M | -90853.00000M | -65604.00000M | 5544.00M |
| Net receivables | 491414.00M | 483064.00M | 442692.00M | 434595.00M | 338640.00M |
| Long term debt | 847209.00M | 625926.00M | 579424.00M | 413785.00M | 430404.00M |
| Inventory | 719330.00M | 678836.00M | 642553.00M | 540249.00M | 481451.00M |
| Accounts payable | 193583.00M | 213252.00M | 180560.00M | 178092.00M | 142087.00M |
| Total permanent equity | - | - | - | - | - |
| Noncontrolling interest in consolidated entity | - | - | - | - | - |
| Temporary equity redeemable noncontrolling interests | - | - | - | - | - |
| Accumulated other comprehensive income | - | 501513.00M | - | - | - |
| Additional paid in capital | - | - | - | - | - |
| Common stock total equity | - | - | - | - | - |
| Preferred stock total equity | - | - | - | - | - |
| Retained earnings total equity | - | - | - | - | - |
| Treasury stock | - | - | - | - | - |
| Accumulated amortization | - | - | - | - | - |
| Non currrent assets other | 157014.00M | 101755.00M | 8466.00M | 6226.00M | 62895.00M |
| Deferred long term asset charges | - | - | - | - | - |
| Non current assets total | 2245766.00M | 2012693.00M | 1966331.00M | 2014865.00M | 1782164.00M |
| Capital lease obligations | 37587.00M | 38544.00M | 35292.00M | 10939.00M | 4801.00M |
| Long term debt total | - | - | - | - | - |
| Breakdown | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
| Investments | -381150.00000M | -142598.00000M | -213584.00000M | 31589.00M | 10274.00M |
| Change to liabilities | - | - | - | 31576.00M | 1706.00M |
| Total cashflows from investing activities | -381150.00000M | -142598.00000M | - | -221019.00000M | -157751.00000M |
| Net borrowings | 222422.00M | -33673.00000M | - | 94434.00M | -48336.00000M |
| Total cash from financing activities | 144567.00M | -94331.00000M | 111780.00M | 42321.00M | -95869.00000M |
| Change to operating activities | - | - | - | -13276.00000M | 33005.00M |
| Net income | 194602.00M | 43806.00M | -61906.00000M | 215121.00M | 150906.00M |
| Change in cash | 56537.00M | 85595.00M | 4955.00M | 26713.00M | 11464.00M |
| Begin period cash flow | 333498.00M | 247903.00M | 242948.00M | 216235.00M | 204771.00M |
| End period cash flow | 390035.00M | 333498.00M | 247903.00M | 242948.00M | 216235.00M |
| Total cash from operating activities | 301489.00M | 295300.00M | 90804.00M | 183271.00M | 253676.00M |
| Issuance of capital stock | 122.00M | 122.00M | 208.00M | 125.00M | 69.00M |
| Depreciation | 186106.00M | 182196.00M | 176651.00M | 148129.00M | 133272.00M |
| Other cashflows from investing activities | -12115.00000M | -28093.00000M | - | 52.00M | -296.00000M |
| Dividends paid | 49962.00M | 49962.00M | -48575.00000M | -47187.00000M | -45800.00000M |
| Change to inventory | -32068.00000M | -16303.00000M | -84053.00000M | -73257.00000M | 6110.00M |
| Change to account receivables | 2816.00M | -19087.00000M | 8405.00M | -45911.00000M | 5214.00M |
| Sale purchase of stock | -30019.00000M | -12.00000M | -1415.00000M | -412.00000M | -10.00000M |
| Other cashflows from financing activities | 2004.00M | -10806.00000M | 237023.00M | 140889.00M | -33192.00000M |
| Change to netincome | - | - | - | -79111.00000M | -5399.00000M |
| Capital expenditures | 217939.00M | 171954.00M | 172158.00M | 169708.00M | 150292.00M |
| Change receivables | - | - | - | - | - |
| Cash flows other operating | - | - | - | - | - |
| Exchange rate changes | - | - | - | - | - |
| Cash and cash equivalents changes | - | - | - | - | - |
| Change in working capital | -9794.00000M | 998.00M | -81107.00000M | -81756.00000M | 30139.00M |
| Stock based compensation | - | - | - | - | - |
| Other non cash items | -69425.00000M | 68300.00M | 57166.00M | -98223.00000M | -60641.00000M |
| Free cash flow | 83550.00M | 123346.00M | -81354.00000M | 13563.00M | 103384.00M |
Sector: Industrials Industry: Conglomerates
| Company | Change (USD) | Price (USD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| AHKSY Asahi Kaisei Corp |
-0.08 0.36% | 21.87 | 14.83 | 17.70 | 0.0043 | 1.05 | 0.93 | 7.07 |
| HON Honeywell International Inc |
-11.97 5.09% | 223.26 | 23.08 | 19.72 | 3.48 | 8.06 | 3.85 | 15.52 |
| MMM 3M Company |
-1.25 0.82% | 151.65 | 14.69 | 17.76 | 2.45 | 16.54 | 2.55 | 9.07 |
| MSBHF Mitsubishi Corp. |
0.45 1.47% | 31.00 | 10.00 | - | 0.0032 | 1.08 | 0.0046 | 0.05 |
| HTHIY Hitachi Ltd ADR |
0.63 1.96% | 32.84 | 13.55 | 10.63 | 0.0062 | 1.66 | 0.0069 | 0.05 |
Asahi Kasei Corporation engages in material, homes, healthcare businesses. The company offers Pimel photosensitive polyimide/PBO precursor, a liquid photosensitive material for buffer coating and packaging applications; Sunfort dry film photoresist to form circuit patterns on printed wiring boards; Novacure, a latent curing agent for epoxy resin with storage stability; glass fabric for printed circuit boards; plastic optical fiber; suede products under the Dinamica name; Microza UF and MF industrial membranes and systems; Aciplex membranes, process equipment, and systems for caustic soda production; Hipore, a microporous polyolefin sheet which prevents the anode and cathode from contacting one another; Celgard, a lithium-ion battery separator; Deramic, a lead acid battery separator; photopolymers and platemaking systems; and fiber products under the Bemberg, ROICA, ELTAS, Bemliese, EUTEC, Precisé, SEMIA, smash, PULSHUT, Lastan, Cubit, NanoAct, ECORISE, BioCradle, CMC-Bemliese names. It also provides cling film, bags and containers, and dishwashing liquid under the Saran Wrap, Ziploc, Cookper, Frosch names; packaging products under the OPS, Suntec, Barrialon, PVDC latex, and Saran names; pharmaceutical and food additives under the Ceolous and Celphere names; and clads and anchors under the Baclad and AR Chemical Setter names. In addition, the company is involved in the provision of remodeling services; real estate-related operations; offers unit homes and apartment buildings; autoclaved aerated concrete, foundation systems, thermal insulation material, structural systems and components products; prescription drugs in the fields of orthopedics, critical/intensive care, urology, immune system, and central nervous system; enzymes and diagnostic products; and hemodialysis, therapeutic apheresis, and autologous blood-related businesses. The company was founded in 1931 and is headquartered in Tokyo, Japan.
Hibiya Mitsui Tower, Tokyo, Japan, 100-0006
| Name | Title | Year Born |
|---|---|---|
| Mr. Koshiro Kudo | CFO, Presial Exec. Officer, Pres & Representative Director | 1959 |
| Mr. Toshiyasu Horie | Sr. Exec. Officer, Exec. Officer for Strategy, Accounting & Fin., IR and Director | 1962 |
| Futoshi Hamamoto | Gen. Mang. of Investor Relations | NA |
| Hiroki Ideguchi | Sr. Exec. Officer and Exec. Officer for Genl Affairs, Legal, Comm. Risk Mgmt. & Compliance, HR | NA |
| Mr. Shuichi Sakamoto | Primary Exec. Officer for Health Care Bus. Sector (joint) & Director | 1957 |
| Dr. Ichiro Oyama M.D. | Chief Industrial Physician | NA |
| Mr. Richard A. Packer | Primary Exec. Officer & Exec. Officer for Health Care Bus. Sector (Joint) | 1958 |
| Mr. Kenji Hamai | Primary Exec. Officer | NA |
| Hideyuki Yamagishi | Primary Exec. Officer | NA |
| Mr. John W. Moyer | Sr. Exec. Officer | NA |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.